Initial evaluation of extracorporeal immunomodulatory therapy for the treatment of critically ill COVID-19 infected patients

Severe COVID-19 infection results in significant immune dysregulation resulting from excessive recruitment and activation of neutrophils. The aim of this study was to confirm feasibility, initial safety and detect signal of efficacy of a non-propriety device delivered using an intermittent extra-cor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemoine, Sandrine, Penny, Jarrin, Fraser, Douglas D., Salerno, Fabio R., Dorie, Justin, Tamasi, Tanya, Arntfield, Robert, House, Andrew, Slessarev, Marat, McIntyre, Christopher W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684905/
https://www.ncbi.nlm.nih.gov/pubmed/36424380
http://dx.doi.org/10.1038/s41598-022-21944-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684905/
https://www.ncbi.nlm.nih.gov/pubmed/36424380
http://dx.doi.org/10.1038/s41598-022-21944-4

Ejemplares similares